PharmaLectures.com

Courses › Regulatory affairs by region › European Union: Variations, renewals and lifecycle without drowning in Type IBs

European Union: Variations, renewals and lifecycle without drowning in Type IBs

Your team files variations and renewals that pass first time and keeps batches moving.

  • 10 audio modulesthree lengths each
  • 1 h 40 min to 8 h 20 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • RA, QA, BDwho it is written for

Why this training matters

A Type IB notification goes in with the wrong category on the Module 1.2 form. The authority questions it, and quality assurance cannot release the new batches while the answer is pending. On Monday the regulatory manager is explaining to supply chain why stock is on hold.

What changes after this course

Your team classifies each change against the Classification Guideline, files it in the right procedure and keeps the renewal calendar ahead of the deadline. You hold a certificate for each learner and a training record for each person, ready for the next audit.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

A manufacturing site change lands on your desk on Tuesday. You open the Classification Guideline under Commission Regulation (EC) No 1234/2008, find the condition that applies, and file it as Type IA, Type IB or Type II without waiting for a second opinion. The Module 1.2 form carries the right category first time, so there is far less for an assessor to query.

Before an inspector from a national competent authority arrives, your pharmacovigilance team opens the Pharmacovigilance System Master File and checks it against Good Pharmacovigilance Practices Module II. The Qualified Person responsible for pharmacovigilance knows which records will be asked for, and the reporting clocks for adverse drug reactions sit on one page. Questions get answered from the file, not from memory.

Ahead of a licensing deal, a business development lead opens the target's dossier history and checks it. Is the five-year renewal filed? Are the Periodic Safety Update Reports on the reference dates list up to date? Does the Risk Management Plan reflect the latest safety signal? The answers reach the negotiating table before the price does.

Renewal stops being a surprise. Under Directive 2001/83/EC and Regulation (EC) No 726/2004 the application goes in at least nine months before the five years end, so your team counts back from that date, builds the consolidated file with the clinical overview, and files with time to spare. Supply chain keeps shipping because nobody is waiting on an authorisation.

Who needs this training

  • Regulatory Affairs Manager

    Decides on a Tuesday whether a site change is Type IA, Type IB or Type II, and files the Module 1.2 form without a week of emails to colleagues and consultants.

  • Quality Assurance Specialist

    Audits the pharmacovigilance system against Good Pharmacovigilance Practices and checks that the change control record matches what was filed, so batch release does not wait on a regulatory query.

  • Business Development Lead

    Reads a target's dossier history before the term sheet and spots a missed renewal, an overdue Periodic Safety Update Report or an open Risk Management Plan update.

Roles: Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Classify a manufacturing change as Type IA, Type IB or Type II by finding the matching condition in the Classification Guideline.
  2. Complete the Module 1.2 application form with the correct category so the submission passes validation.
  3. Choose between grouping, worksharing and separate submissions when several variations affect the same product.
  4. Calculate the renewal submission date by counting back nine months from the end of the five-year period.
  5. Place a quality change in Module 3 and its summary in Module 2 following the International Council for Harmonisation M4 layout.
  6. Check a Pharmacovigilance System Master File against Good Pharmacovigilance Practices Module II before an inspector does.
  7. Sequence concurrent variations across member states so that no two changes to the same product collide.

What the company gets

  • Batches stop waiting in quarantine for answers to avoidable questions about the category of a Type IB variation.
  • Every five-year renewal has an internal deadline set well before the date the authority needs it, so no authorisation is put at risk.
  • An inspector asking for the Pharmacovigilance System Master File gets a file that is ready, current and organised to match Good Pharmacovigilance Practices.
  • Buyers and licensing partners get a straight answer on the dossier history of a product, from variations filed to safety updates submitted.
  • Hours spent drafting replies to avoidable deficiency letters go back to planned work, and each learner's certificate and training record sit ready for your next audit.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 10 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h 40 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard4 h 10 min25 min a module, for regulatory, quality and business-development staff
Expanded8 h 20 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Business development and export salesBriefing1 h 40 min
Regulatory affairsStandard4 h 10 min
Quality assurance and Qualified PersonStandard4 h 10 min

Course outline: 10 modules

10 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Map who decides what for medicinal products across the European Union

    • How to tell in one minute which authority owns the decision on your product's change.
    • The one question that stops a launch plan from committing you to the wrong procedure.
    • What to do when a national authority and the European Medicines Agency seem to disagree.
  2. 2Meet Marketing Authorisation Holder duties under Directive 2001/83/EC

    • How to answer, on the spot, what Directive 2001/83/EC requires of a Marketing Authorisation Holder.
    • Why an unreported change to the dossier becomes an inspection question, and how to prevent it.
    • Who in your company signs off a lifecycle change, so nobody chases a signature on deadline day.
  3. 3Classify Type IA, Type IB and Type II variations without second-guessing

    • How to find the exact condition in the Classification Guideline that decides Type IA or Type IB.
    • When a change that looks minor is a Type II variation, and when it is not.
    • Why a change missing from the guideline defaults to Type IB, and how to ask for a recommendation.
  4. 4Choose the right European procedure for each variation and submit it

    • How to decide between grouping, worksharing and separate submissions in one short meeting.
    • What to put in the Module 1.2 application form so the submission passes validation first time.
    • The timetable you can quote to supply chain when a Type IB notification goes in on a given day.
  5. 5Assemble electronic Common Technical Document files assessors accept

    • How to place a quality change in Module 3 so the assessor finds the data without asking.
    • Why a Module 2 summary that answers the obvious question saves you a request for more information.
    • The International Council for Harmonisation M4 layout rules that stop a file bouncing at validation.
  6. 6Run the five-year renewal of your marketing authorisations on time

    • How to count back nine months from the five-year date and set an internal deadline that holds.
    • How to build the consolidated file and clinical overview so the benefit-risk case reads in one sitting.
    • What to do when the renewal file and the live dossier disagree on a detail.
  7. 7Fold safety updates and Risk Management Plans into your lifecycle

    • How to read your Periodic Safety Update Report due dates straight from the reference dates list.
    • How to turn a new safety signal into a Risk Management Plan update before the next assessment.
    • The product information change a new adverse drug reaction forces, and the variation that carries it.
  8. 8Keep your Pharmacovigilance System Master File ready for inspection

    • What your Qualified Person for pharmacovigilance must be able to show when an inspector asks.
    • How to lay out the Pharmacovigilance System Master File so every request is answered from one place.
    • Why the reporting clocks for adverse drug reactions belong on one page your team can see.
  9. 9Plan concurrent variations across member states without collisions

    • How to sequence changes across member states so one approval does not break another.
    • Why a one-page portfolio calendar stops two changes to the same product colliding.
    • What to do when a new European rule lands on an older marketing authorisation in your portfolio.
  10. 10Pass Good Pharmacovigilance Practices inspections without findings

    • What inspectors ask first in a Good Pharmacovigilance Practices inspection, and who should answer.
    • How to produce variation and renewal records on request without a frantic search of the archive.
    • The recurring inspection findings and the check that heads each one off.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

10 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h 40 min in the briefing length and 8 h 20 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for RA, QA, BD. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 90 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team